1-4 of 4
R. Foà
Close
Sort by
Journal Articles

A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.

B. Bruno, MD, M. Rotta, MD, F. Patriarca, MD, D. Mattei, MD, B. Allione, MD, F. Carnevale-Schianca, MD, A. Rambaldi, MD, M. Casini, MD, V. Montefusco, MD, M. Parma, MD, P. Bavaro, MD, F. Onida, MD, A. Busca, MD, L. Castagna, MD, M.P. Iori, MD, D. Maloney, MD, B. Sandmaier, MD, F. Benedetti, MD, N. Mordini, MD, L. Giaccone, MD, R. Sorasio, MD, F. Fiore, MD, A. Filippi, MD, A. Palumbo, MD, M. Aglietta, MD, A. Levis, MD, R. Foà, MD, P. Di Bartolomeo, MD, E. Pogliani, MD, G. Lambertenghi-Deliliers, MD, M. Falda, MD, M. Petrini, MD, P. Corradini, MD, R. Fanin, MD, U. Ricardi, MD, R. Storb, MD, I. Baldi, B.Sc, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 3026.
https://doi.org/10.1182/blood.V110.11.3026.3026
Published: 2007
Journal Articles

High-Resolution Genomic Profiling of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukaemia (ALL) Identified Novel Recurrent Copy Number Variations Involved in Both Pathogenesis and Resistance to Tyrosine Kinase Inhibitors.

Ilaria Iacobucci, E. Ottaviani, A. Astolfi, S. Soverini, N. Testoni, S. Paolini, P.P. Piccaluga, C. Papayannidis, D. Cilloni, A. Pession, F. Pane, A. Vitale, S. Chiaretti, R. Foà, M. Baccarani, Giovanni Martinelli
Journal: Blood
Blood (2007) 110 (11): 230.
https://doi.org/10.1182/blood.V110.11.230.230
Published: 2007
Journal Articles

The Overexpression of Spliced Oncogenic Ikaros Isoforms in Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients Is a New Mechanism of Resistance to Tyrosine Kinase Inhibitors.

I. Iacobucci, A. Lonelti, E. Ottaviani, D. Cilloni, F. Messa, S. Paolini, C. Papayannidis, G. Panagiota, S. Soverini, M. Amabile, A. Poerio, M. Rondoni, G. Saglio, F. Pane, G. Berton, A. Baruzzi, A. Vitale, R. Foà, M. Baccarani, Giovanni Martinelli
Journal: Blood
Blood (2007) 110 (11): 722.
https://doi.org/10.1182/blood.V110.11.722.722
Published: 2007
Journal Articles

High Levels of Tumor Load Reduction after Intensive Chemotherapy Favorably Affect the Prognosis of BCR/ABL+ ALL Adult Patients Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PhD, Fabrizio Pane, MD, M. Vignetti, MD, P. Fazi, MD, S. Iacobelli, PhD, G. Meloni, MD, A. Vitale, MD, V. Martini, MD, G. Martinelli, MD, F. Di Raimondo, MD, M. Bonifacio, MD, F. Fabbiano, MD, G. Saglio, MD, M. Baccarani, MD, R. Foà, MD, F. Mandelli, MD
Journal: Blood
Blood (2006) 108 (11): 638.
https://doi.org/10.1182/blood.V108.11.638.638
Published: 2006